Adicet Bio, Inc. (LON:0HX7)
London · Delayed Price · Currency is GBP · Price in USD 6.99
-0.27 (-3.77%)
Feb 11, 2026, 2:29 PM GMT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of 49.86 million as of February 12, 2026. Its market cap has decreased by -23.67% in one year.
Market Cap
49.86M
Enterprise Value
-14.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.99
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from 232.15M to 49.86M, a decrease of -78.52%. That is a compound annual growth rate of -24.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 50.44M | -20.22% |
| Dec 31, 2025 | 63.23M | -9.43% |
| Dec 31, 2024 | 69.81M | 8.99% |
| Dec 29, 2023 | 64.05M | -79.86% |
| Dec 30, 2022 | 317.95M | -37.12% |
| Dec 31, 2021 | 505.60M | 150.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Creo Medical Group | 70.84M |
| Hemogenyx Pharmaceuticals | 55.28M |
| SkinBioTherapeutics | 51.78M |
| BATM Advanced Communications | 51.52M |